CCL3 and colorectal carcinoma: De la Fuente López [18] et al. confirmed Ma et al.’s [17] observations in a clinical cohort (n = 48), reporting significantly higher plasma levels of CCL2, CCL3, and CCL4 in CRC patients versus healthy controls.